Induction of atypical EAE mediated by transgenic production of IL-6 in astrocytes in the absence of systemic IL-6

GLIA

Volumn 61, Issue 4, 2013, Pages 587-600

  Giralt, Mercedes ^a   Ramos, Raquel ^a   Quintana, Albert ^a,c   Ferrer, Beatriz ^a   Erta, Maria ^a   Castro Freire, Marco ^a,d   Comes, Gemma ^a   Sanz, Elisenda ^a,c   Unzeta, Mercedes ^a   Pifarré, Paula ^a   García, Agustina ^a   Campbell, Iain L ^b   Hidalgo, Juan ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

Astrocyte; Autoimmunity; Microglia; T cells

Indexed keywords

INTERLEUKIN 6; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; AUTOIMMUNITY; CEREBELLUM; CYTOKINE PRODUCTION; DEMYELINATION; FEMALE; INFLAMMATORY CELL; MALE; MICROGLIA; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SPINAL CORD;

ANIMALS; ASTROCYTES; CELLS, CULTURED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC;

EID: 84873704313     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22457     Document Type: Article

References (38)

1. Afzali B, Mitchell P, Lechler RI, John S, Lombardi G. 2010. Translational mini-review series on Th17 cells: Induction of interleukin-17 production by regulatory T cells. Clin Exp Immunol 159: 120-130.
2. Asensio VC, Campbell IL. 1997. Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis. J Virol 71: 7832-7840.
3. Benveniste EN. 1997. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J Mol Med (Berl) 75: 165-173.
4. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
5. Brett FM, Mizisin AP, Powell HC, Campbell IL. 1995. Evolution of neuropathological abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J Neuropathol Exp Neurol 54: 766-775.
6. Buniatian G, Gebhardt R, Schrenk D, Hamprecht B. 1996. Colocalization of three types of intermediate filament proteins in perisinusoidal stellate cells: Glial fibrillary acidic protein as a new cellular marker. Eur J Cell Biol 70: 23-32.
7. Campbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MBA, Mucke L. 1993. Neurologic disease in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci USA 90: 10061-10065.
8. Chiang C-S, Powell HC, Gold LS, Samimi A, Campbell IL. 1996. Macrophage/microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice. J Clin Invest 97: 1512-1524.
9. Chiang C-S, Stalder A, Samimi A, Campbell IL. 1994. Reactive gliosis as a consequence of interleukin 6 expression in the brain: Studies in transgenic mice. Dev Neurosci 16: 212-221.
10. Daley JM, Thomay AA, Connolly MD, Reichner JS, Albina JE. 2008. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol 83: 64-70.
11. Danielyan LG, Gebhardt R, Buniatian GH. 2008. Expression of glial fibrillary acidic protein in the rat endocard, cardiac interstitial Cajal-like cells, and perivascular structures of the spleen. Neurochem J 2: 293-296.
12. Eugster HP, Frei K, Kopf M, Lassmann H, Fontana A. 1998. IL-6 deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur J Immunol 28: 2178-2187.
13. Eugster HP, Frei K, Winkler F, Koedel U, Pfister W, Lassmann H, Fontana A. 2001. Superantigen overcomes resistance of IL-6-deficient mice towards MOG-induced EAE by a TNFR1 controlled pathway. Eur J Immunol 31: 2302-2312.
14. Fleming TJ, Fleming ML, Malek TR. 1993. Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J Immunol 151: 2399-2408.
15. Heppner FL, Greter M, Marino D, Falsig J, Raivich G, Hövelmeyer N, Waisman A, Rülicke T, Prinz M, Priller J, Becher B, Aguzzi A. 2005. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat Med 11: 146-152.
16. Hidalgo J, Florit S, Giralt M, Ferrer B, Keller C, Pilegaard H. 2010. Transgenic mice with astrocyte-targeted production of interleukin-6 are resistant to high-fat diet-induced increases in body weight and body fat. Brain Behav Immun 24: 119-261.
17. Hobbs MV, Weigle WO, Noonan DJ, Torbett BE, McEvilly RJ, Koch RJ, Cardenas GJ, Ernst DN. 1993. Patterns of cytokine gene expression by CD4+ T cells from young and old mice. J Immunol 150: 3602-3608.
18. Jones SA. 2005. Directing transition from innate to acquired immunity: Defining a role for IL-6. J Immunol 175: 3463-3468.
19. Kishimoto T, Akira S, Narazaki M, Taga T. 1995. Interleukin-6 family of cytokines and gp130. Blood 86: 1243-1254.
20. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R, Bluethmann H, Köhler G. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368: 339-342.
21. Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, Langer-Gould A, Strober S, Cannella B, Allard J, Klonowski P, Austin A, Lad N, Kaminski N, Galli SJ, Oksenberg JR, Raine CS, Heller R, Steinman L. 2002. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 8: 500-508.
22. Martiney JA, Rajan AJ, Charles PC, Cerami A, Ulrich PC, Macphail S, Tracey KJ, Brosnan CF. 1998. Prevention and treatment of experimental autoimmune encephalomyelitis by CNI-1493, a macrophage-deactivating agent. J Immunol 160: 5588-5595.
23. Mendel I, Katz A, Kozak N, Ben-Nun A, Revel M. 1998. Interleukin-6 functions in autoimmune encephalomyelitis: A study in gene-targeted mice. Eur J Immunol 28: 1727-1737.
24. Metten P, Best KL, Cameron AJ, Saultz AB, Zuraw JM, Yu CH, Wahlsten D, Crabbe JC. 2004. Observer-rated ataxia: Rating scales for assessment of genetic differences in ethanol-induced intoxication in mice. J Appl Physiol 97: 360-368.
25. Mycko MP, Papoian R, Boschert U, Raine CS, Selmaj KW. 2003. cDNA microarray analysis in multiple sclerosis lesions: Detection of genes associated with disease activity. Brain 126: 1048-1057.
26. Okuda Y, Sakoda S, Bernard CC, Fujimura H, Saeki Y, Kishimoto T, Yanagihara T. 1998. IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein. Int Immunol 10: 703-708.
27. Okuda Y, Sakoda S, Fujimura H, Saeki Y, Kishimoto T, Yanagihara T. 1999. IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glucoprotein 35-55 induced experimental autoimmune encephalomyelitis. J Neuroimmunol 101: 188-196.
28. Palmer MT, Weaver CT. 2010. Autoimmunity: Increasing suspects in the CD4+ T cell lineup. Nat Immunol 11: 36-40.
29. Quintana A, Müller M, Frausto RF, Ramos R, Getts DR, Sanz E, Hofer MJ, Krauthausen M, King NJ, Hidalgo J, Campbell IL. 2009. Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitis. J Immunol 183 2079-2088.
30. Raber J, O'Shea RD, Bloom FE, Campbell IL. 1997. Modulation of hypothalamic-pituitary-adrenal function by transgenic expression of interleukin-6 in the CNS of mice. J Neurosci 17: 9473-9480.
31. Rose-John S, Waetzig GH, Scheller J, Grötzinger J, Seegert D. 2007. The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin Ther Targets 11: 613-624.
32. Samoilova EB, Horton JL, Hilliard B, Liu TS, Chen Y. 1998. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: Roles of IL-6 in the activation and differentiation of autoreactive T cells. J Immunol 161: 6480-6486.
33. Señarís RM, Trujillo ML, Navia B, Comes G, Ferrer B, Giralt M, Hidalgo J. 2011. Interleukin-6 regulates the expression of hypothalamic neuropeptides involved in body weight in a gender-dependent way. J Neuroendocrinol 23: 675-686.
34. Steinman L. 2007. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 13: 139-145.
35. Su M, Hu H, Lee Y, d'Azzo A, Messing A, Brenner M. 2004. Expression specificity of GFAP transgenes. Neurochem Res 29: 2075-2093.
36. Swanborg RH. 1995. Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease. Clin Immunol Immunopathol 77: 4-13.
37. Tran EH, Hoekstra K, van Rooijen N, Dijkstra CD, Owens T. 1998. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J Immunol 161: 3767-3775.
38. Weiner HL, Selkoe DJ. 2002. Inflammation and therapeutic vaccination in CNS diseases. Nature 420: 879-884.